Newborn Screening Testing Market Report 2024 (Global Edition)

Global Newborn Screening Testing Market Report 2024 Market Size Split by Type (Hearing Screening Test, Critical Congenital Heart Disease Test CCHD Test, Dry Blood Spot Test, Others), by Technology (Ta...

Newborn Screening Testing Market Report Description

We have various report editions of Newborn Screening Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Newborn Screening Testing Market Insights Video

Competitive Landscape of the Newborn Screening Testing Market

The competitive landscape of the newborn screening testing market is characterized by a mix of established players and emerging innovators. Leading companies like PerkinElmer, Abbott, and Roche dominate with advanced technologies and comprehensive screening solutions. They focus on enhancing test accuracy and expanding screening panels. New entrants and specialized firms, such as Glycominds, drive innovation in niche areas. Competition is driven by technological advancements, regulatory compliance, and the growing demand for early diagnostic tools and comprehensive screening programs.

In June 2021, Texas Health and Human Services introduced newborn screening for Spinal Muscular Atrophy (SMA), contributing to the growing importance of early diagnosis in preventing severe health outcomes. As more such initiatives are implemented, the newborn screening market is poised for substantial growth during the forecast period. (Source: https://www.dshs.texas.gov/newborn-screening-program) In March 2022, Oxford University has launched a population-based newborn screening study in the Thames Valley region. This screening will be conducted through the standard UK newborn blood spot screening process, utilizing the extra sample from a newborn's Guthrie card (dried blood spot). (Source: https://www.ox.ac.uk/news/2022-03-11-first-uk-pilot-study-newborn-screening-spinal-muscular-atrophy-launched-oxford) In July 2020, PerkinElmer Inc. introduced a dry blood spot (DBS) test for SARS-CoV-2 IgG using its GSP/DELFIA platform, capable of processing up to 5,000 samples daily. The test runs on PerkinElmer's GSP analyzer, and with the DELFIA platform’s time-resolved fluorescence (TRF), it helps screen over 30% of all newborns globally, covering 32 countries. (Source: https://www.clinicallab.com/perkinelmer-releases-new-dried-blood-spot-based-covid-19-serology-test-23359)

Top Companies Market Share in Newborn Screening Testing Industry: (In no particular order of Rank)

• PerkinElmer
• Inc.
• Abbott Laboratories
• Roche Diagnostics
• Glycominds
• NantHealth
• Inc.
• Agilent Technologies
• HemoCue (a part of Radiometer)
• Bio-Rad Laboratories
• Inc.
• Trinity Biotech
• LabCorp (Laboratory Corporation of America)
• Siemens Healthineers
• Genzyme (a Sanofi company)
• Becton
• Dickinson and Company (BD)
• Sonic Healthcare
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Newborn Screening Testing Market

Which Region Dominates the Newborn Screening Testing Market in 2024?

According to Cognitive Market Research, North America currently dominates the Newborn Screening Testing market, and the region is expected to have significant growth during the projected period. This is due to the region's well-established healthcare infrastructure and extensive government programs mandating newborn screenings. High awareness levels among parents and healthcare providers, along with significant investments in advanced diagnostic technologies, contribute to market dominance. Additionally, robust research and development activities, coupled with a high standard of healthcare services, support early detection and comprehensive screening, driving growth in the region.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is growing at the fastest CAGR in the newborn screening testing market due to increasing healthcare investments, expanding healthcare infrastructure, and rising awareness about early detection of congenital disorders. Government initiatives to improve healthcare access and the growing prevalence of genetic disorders drive demand. Additionally, rising disposable incomes and urbanization contribute to higher healthcare spending, fostering adoption of advanced newborn screening technologies and services in the region.

The current report Scope analyzes Newborn Screening Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Newborn Screening Testing Market

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 325.0 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Newborn Screening Testing market with a market size of USD 256.43 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The U.S. market's increasing government initiatives for early detection of genetic disorders, a well-established healthcare infrastructure, and rising awareness among parents about the benefits of newborn screening is driving the Newborn Screening Testing market.
• The Canada Newborn Screening Testing market had a market share of USD 39.00 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada’s higher healthcare spending is driving the Newborn Screening Testing market.
• The Mexico Newborn Screening Testing market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 29.58 million in 2024.

Europe Newborn Screening Testing Market

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 395.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Newborn Screening Testing market had a market share of USD 40.95 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, Newborn Screening Testing sales witness an upswing due to strong government mandates for screening programs and rising awareness about early detection of genetic and metabolic disorders.
• The France Newborn Screening Testing market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 22.43 million in 2024.
• According to Cognitive Market Research, the German Newborn Screening Testing market size was valued at USD 48.26 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, Newborn Screening Testing surged due to presence of major market players.
• The Italy Newborn Screening Testing market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 20.96 million in 2024.
• The Russia Newborn Screening Testing market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 37.78 million in 2024.
• The Spain Newborn Screening Testing market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 19.99 million in 2024
• The Luxembourg Newborn Screening Testing market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 7.56 million in 2024.
• The Portugal Newborn Screening Testing market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 5.12 million in 2024.
• The Greece Newborn Screening Testing market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 2.93 million in 2024.
• The Rest of Europe's Newborn Screening Testing market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 37.78 million in 2024.

Asia Pacific Newborn Screening Testing Market

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 186.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Newborn Screening Testing market size was valued at USD 84.09 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Newborn Screening Testing surged in China due to increasing government initiatives to expand healthcare access and improve infant health outcomes.
• The Japan Newborn Screening Testing market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 25.79 million in 2024.
• The India Newborn Screening Testing market had a market share of USD 22.43 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. India's improving healthcare infrastructure is driving the Newborn Screening Testing market .
• The South Korean Newborn Screening Testing market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 18.69 million in 2024.
• The Australian Newborn Screening Testing market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 9.72 million in 2024.
• The South East Asia Newborn Screening Testing market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 12.89 million in 2024.
• The Rest of Asia Pacific Newborn Screening Testing market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 13.27 million in 2024.

South America Newborn Screening Testing Market

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 40.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Newborn Screening Testing market size was valued at USD 17.39 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Newborn Screening Testing flourished in Brazil due to increasing government efforts to improve child healthcare, particularly through expanded newborn screening programs.
• Argentina's Newborn Screening Testing market had a market share of USD 6.83 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Argentina's growing healthcare expenditure is driving the Newborn Screening Testing market.
• Colombia Newborn Screening Testing market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 3.62 million in 2024.
• Peru Newborn Screening Testing market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 3.33 million in 2024.
• Chile Newborn Screening Testing market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 2.93 million in 2024.
• The Rest of Latin America's Newborn Screening Testing market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 6.54 million in 2024.

Middle East and Africa Newborn Screening Testing Market

According to Cognitive Market Research, the global Newborn Screening Testing market size was estimated at USD 812.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 16.25 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries Newborn Screening Testing market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 6.96 million in 2024. Newborn Screening Testing sales flourish due to the presence of major market players.
• The Egypt Newborn Screening Testing market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 1.71 million in 2024.
• The South Africa Newborn Screening Testing market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 2.57 million in 2024. Newborn Screening Testing sales flourished in South Africa due to increased government initiatives and investments in healthcare infrastructure.
• The Turkey Newborn Screening Testing market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.40 million in 2024.
• The Nigeria Newborn Screening Testing market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 1.71 million in 2024.
• The Rest of the MEA Newborn Screening Testing market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1.92 million in 2024.

Newborn Screening Testing Market Analysis

Newborn Screening Testing Market Type Segment Analysis

According to Cognitive Market Research, Hearing Screening Test are likely to dominate the Newborn Screening Testing Market over the forecast period. Hearing screening test types captured the largest market share in the newborn screening testing market due to their critical role in early detection of hearing impairments, which can significantly impact language development and overall quality of life. Hearing tests are widely implemented and often mandated by health policies, leading to their broad adoption. Their effectiveness in identifying hearing loss early and the availability of efficient, non-invasive testing methods contribute to their dominant market share.

The Critical Congenital Heart Disease (CCHD) test type is growing at the highest CAGR in the newborn screening testing market due to increasing awareness of its importance in early detection of potentially life-threatening heart conditions. Advances in non-invasive testing technologies and the effectiveness of early diagnosis in improving outcomes drive demand. Enhanced government and healthcare policies promoting CCHD screening, along with rising incidences of congenital heart defects, further contribute to the rapid growth of this test type.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Newborn Screening Testing Industry. Request a Free Sample PDF!

Newborn Screening Testing Market Technology Segment Analysis

According to Cognitive Market Research, the Tandem Mass Spectrometry segment holds the largest share of the market. Tandem mass spectrometry captured the largest market share in the newborn screening testing market due to its high accuracy and ability to simultaneously detect multiple metabolic disorders from a single blood sample. Its comprehensive screening capability, combined with sensitivity and precision, makes it the preferred choice for identifying a wide range of congenital and metabolic conditions. Additionally, advancements in technology and increased adoption by healthcare systems have further solidified its leading position in the market.

Pulse oximetry technology is growing at the highest CAGR in the newborn screening testing market due to its non-invasive, rapid, and effective method for detecting critical congenital heart diseases (CCHD) in newborns. Its ability to measure oxygen levels in the blood and identify potential heart conditions early has led to widespread adoption. Increased awareness of early diagnosis benefits, coupled with advancements in pulse oximetry technology and supportive healthcare policies, is driving its rapid market growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Newborn Screening Testing Application Segment Analysis

Newborn Screening Testing Market Application Segment Analysis

According to Cognitive Market Research, The Hospitals segment holds the largest market share. The hospitals application captured the largest market share in the newborn screening testing market due to the central role hospitals play in delivering comprehensive newborn care. Hospitals are equipped with advanced screening technologies and skilled healthcare professionals to conduct and interpret tests. They provide a wide range of screening services as part of routine newborn care, making them the primary setting for implementing and managing screening programs. The integration of screening into hospital protocols ensures broad adoption and significant market share.

The clinics application is growing at the highest CAGR in the newborn screening testing market due to increasing accessibility and convenience for families. Clinics offer specialized, often more personalized, screening services and are becoming preferred locations for routine tests outside of hospital settings. With advancements in technology and increased focus on preventive healthcare, clinics are expanding their screening offerings. Additionally, the rising number of private and community clinics contributes to their rapid growth in the market.

• Hospitals
• Clinics
• Diagnostic Centers
• Others

Newborn Screening Testing Test Type Segment Analysis

Newborn Screening Testing Market Test Type Segment Analysis

According to Cognitive Market Research, the Dried Blood Spot Hearing Screening segment dominates the market. The dried blood spot hearing screening test type captured the largest market share in the newborn screening testing market due to its effectiveness and convenience. It involves collecting a small blood sample on filter paper, which is then analyzed for various disorders, including hearing impairments. This method is non-invasive, easy to administer, and integrates well into routine newborn care. Its widespread adoption in screening programs and reliability in detecting hearing issues early contribute to its leading market share.

The Critical Congenital Heart Defect (CCHD) test type is growing at the highest CAGR due to its vital role in early detection of severe heart conditions that can significantly impact a newborn’s health. Advances in non-invasive testing technologies have enhanced the accuracy and reliability of CCHD screenings. Increased awareness about the benefits of early diagnosis and the implementation of supportive health policies are driving widespread adoption and rapid growth of this test type in newborn screening programs.

• Dried Blood Spot Hearing Screening
• Critical Congenital Heart Defect

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion